As of Aug 26
| +0.05 / +0.49%|
The 8 analysts offering 12-month price forecasts for ARIAD Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 13.00 and a low estimate of 8.00. The median estimate represents a -2.44% decrease from the last price of 10.25.
The current consensus among 8 polled investment analysts is to Buy stock in ARIAD Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.